AMG 531: an investigational thrombopoiesis-stimulating peptibody.
about
Use of Thrombopoietin Receptor Agonists in Childhood Immune ThrombocytopeniaNew insights and therapeutics for immune-mediated thrombocytopenia.Romiplostim management of immune thrombocytopenic purpura.New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.The pharmacology and clinical application of thrombopoietin receptor agonists.
P2860
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@ast
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@en
type
label
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@ast
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@en
prefLabel
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@ast
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@en
P356
P1476
AMG 531: an investigational thrombopoiesis-stimulating peptibody.
@en
P2093
Janet L Nichol
P304
P356
10.1002/PBC.20972
P433
P577
2006-10-01T00:00:00Z